Abiopharma

🔍 MARCUS JOEL S (Director)

Company: ALEXANDRIA REAL ESTATE EQUITIES, INC. (ARE)

Report Date: 2026-05-05

Detailed Transactions and Holdings:

• Acquired 2,062 shares of Common Stock at $41.89 per share (Direct)
  Date: 2026-05-05 | Code: P | equity_swap_involved: 0 | shares_owned_after: 574,786.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 3,832 shares of Common Stock at $42.76 per share (Direct)
  Date: 2026-05-05 | Code: P | equity_swap_involved: 0 | shares_owned_after: 578,618.00 | transaction_form_type: 4 | Footnotes: F2
• Acquired 1,606 shares of Common Stock at $43.7 per share (Direct)
  Date: 2026-05-05 | Code: P | equity_swap_involved: 0 | shares_owned_after: 580,224.00 | transaction_form_type: 4 | Footnotes: F3

Footnotes:

• F1: The shares were purchased at prices ranging from $41.36 to $42.36. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares purchased at each separate price.
• F2: The shares were purchased at prices ranging from $42.38 to $43.35. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares purchased at each separate price.
• F3: The shares were purchased at prices ranging from $43.41 to $43.97. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares purchased at each separate price.